These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 34336446)

  • 1. Acute Pancreatitis-Induced Euglycemic Diabetic Ketoacidosis.
    Chaudhry A; Biggiani C; Afzal M; Chaudhry S; Vwich Y
    Cureus; 2021 Jun; 13(6):e15949. PubMed ID: 34336446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SGLT-2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report and a Literature Review.
    Mahfooz RS; Khan MK; Al Hennawi H; Khedr A
    Cureus; 2022 Jun; 14(6):e26267. PubMed ID: 35911365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Euglycemic Diabetic Ketoacidosis Caused by Alcoholic Pancreatitis and Starvation Ketosis.
    Han HJ; Cole AE; Verma A
    J Gen Intern Med; 2023 Apr; 38(5):1299-1301. PubMed ID: 36689144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A systematic review and network meta-analysis.
    Hussein H; Zaccardi F; Khunti K; Davies MJ; Patsko E; Dhalwani NN; Kloecker DE; Ioannidou E; Gray LJ
    Diabetes Obes Metab; 2020 Jul; 22(7):1035-1046. PubMed ID: 32077218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemic, high anion-gap metabolic acidosis in patients receiving SGLT-2 inhibitors for diabetes management.
    Kum-Nji JS; Gosmanov AR; Steinberg H; Dagogo-Jack S
    J Diabetes Complications; 2017 Mar; 31(3):611-614. PubMed ID: 27913012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus.
    Chauhan S; Manov A; Dhillon GS; Shah P
    Cureus; 2023 Jan; 15(1):e33892. PubMed ID: 36819400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Euglycemic diabetic ketoacidosis in a patient with acute stroke taking sodium glucose co-transporter 2 inhibitor.
    Pathak BD; Dhakal B; Bhattarai AM; Regmi BU; Mandal SK; Panta PR; Khadka S; Simkhada N
    Ann Med Surg (Lond); 2022 Jul; 79():104118. PubMed ID: 35860094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Euglycemic Diabetic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor Use Post-Bariatric Surgery: A Brief Review of the Literature.
    Iqbal QZ; Mishiyev D; Zia Z; Ruggiero RA; Aftab G
    Cureus; 2020 Oct; 12(10):e10878. PubMed ID: 33178530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DKA that wasn't: a case of euglycemic diabetic ketoacidosis due to empagliflozin.
    Candelario N; Wykretowicz J
    Oxf Med Case Reports; 2016 Jul; 2016(7):144-6. PubMed ID: 27471597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature.
    Diaz-Ramos A; Eilbert W; Marquez D
    Int J Emerg Med; 2019 Sep; 12(1):27. PubMed ID: 31488052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis.
    Fernandez Felix DA; Madrigal Loria G; Sharma S; Sharma S; Arias Morales CE
    Cureus; 2022 Jun; 14(6):e25818. PubMed ID: 35698468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Euglycemic Diabetic Ketoacidosis Induced by Sodium-Glucose Cotransporter-2 Inhibitor Use and Coronary Angiography: A Case Report.
    VonTungeln CD; Al Bataineh M
    Cureus; 2024 Jan; 16(1):e52122. PubMed ID: 38344581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Euglycemic diabetic ketoacidosis: A missed diagnosis.
    Nasa P; Chaudhary S; Shrivastava PK; Singh A
    World J Diabetes; 2021 May; 12(5):514-523. PubMed ID: 33995841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis.
    Calçada MB; Fernandes L; Soares Costa R; Montezinho S; Martins Duarte F; Frutuoso L; Freitas AR
    Clin Pract; 2021 Apr; 11(2):216-218. PubMed ID: 33917274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spotlight on Canagliflozin 300: review of its efficacy and an indirect comparison to other SGLT-2 inhibitors and long-acting GLP-1 receptor agonists.
    Singh AK; Singh R
    Expert Rev Clin Pharmacol; 2017 Jun; 10(6):633-647. PubMed ID: 28393583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Euglycemic Diabetic Ketoacidosis Caused by a Sodium-glucose Co-transporter (SGLT) 2 Inhibitor after Coronary Artery Bypass Grafting].
    Kameda Y; Kato M; Inoue B; Yamazaki S; Sahara N; Aoki T; Nagashima Y; Nemoto N; Anzai H; Araki W; Kobayashi N
    Kyobu Geka; 2019 May; 72(5):354-357. PubMed ID: 31268032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Euglycemic Diabetic Ketoacidosis Due to SGLT2 Inhibitor in a Patient With Gitelman Syndrome: A Therapeutic Dilemma.
    Ahmed T; Karimi H; Hegde V; Lodhi SH
    Cureus; 2021 Oct; 13(10):e19169. PubMed ID: 34873512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Euglycemic Diabetic Ketoacidosis Precipitated by SGLT-2 Inhibitor Use, Pericarditis, and Fasting: A Case Report.
    Mendelsohn RA; Taveras AN; Mazer BA; Clayton LM
    Clin Pract Cases Emerg Med; 2020 Aug; 4(3):389-392. PubMed ID: 32926693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium-Glucose Linked Transporter Inhibitors as a Cause of Euglycemic Diabetic Ketoacidosis on a Background of Starvation.
    Tauseef A; Asghar MS; Zafar M; Lateef N; Thirumalareddy J
    Cureus; 2020 Aug; 12(8):e10078. PubMed ID: 33005504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors - A Case Series.
    Sharma PV; Jobanputra YB; Lewin K; Bagatell S; Lichtstein DM
    Rev Recent Clin Trials; 2018; 13(2):156-160. PubMed ID: 29542418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.